Assenagon Asset Management
NXTM

Assenagon Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Assenagon Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-82,418
Closed -$2.3M – 1220
2018
Q3 		$2.3M Buy
+82,418
New +$2.32M 0.02% 490
2018
Q2 		– Sell
-431,804
Closed -$10.7M – 644
2018
Q1 		$10.7M Buy
+431,804
New +$10.5M 0.14% 157

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management's NXTM Position: Q4 2018 in Review

Assenagon Asset Management sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 82,418 shares — an estimated $2.3M sold.

Assenagon Asset Management first reported a position in NXTM in Q1 2018 and held it in 2 quarters. The position peaked at $10.7M in Q1 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Assenagon Asset Management reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Assenagon Asset Management sold 82,418 NxStage Medical Inc. shares in Q4 2018, an estimated $2.3M.
  • Assenagon Asset Management first reported a position in NxStage Medical Inc. in Q1 2018 and held it in 2 quarters.
  • Assenagon Asset Management's NxStage Medical Inc. position peaked at $10.7M in Q1 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Assenagon Asset Management's 13F filing for Q4 2018, filed 23 Jan 2019.